← Evidence map

ArticleFrontline gastroenterology2024

Erratum: Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Erratum: Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II). | OpenQuestion